Thomas Lunt

Called to the bar 2018 Junior


Thomas’ practice encompasses all areas in intellectual property. He has been instructed in matters involving patents and SPCs, trade marks, passing off, copyright, and confidential information in addition to commercial matters of a technical nature.


Selected cases:


AutoStore Technology v Ocado Group PLC & ors (ongoing) – automated robotic storage and retrieval technology in patent infringement and entitlement actions

Sandoz, Teva v Bristol-Myers Squibb [2022] EWHC 822 (Pat)– pharmaceutical patents action concerning the blockbuster anticoagulant apixaban

Dr Reddy’s, Actavis, NHS England & ors v Warner-Lambert, Pfizer [2021] EWHC 2182 (Ch) (ongoing) – damages inquiry emanating from long-running pregabalin litigation

Advanced Bionics v Med-El [2021] EWHC 2415 (Pat) – a successful expedition application for cochlear implant patent litigation proceeding on the Shorter Trials Scheme

Edwards Lifesciences Corp v Meril GmbH [2021] EWHC 761 (Pat) – prosthetic aortic valve medical device litigation

Akebia v Fibrogen, Astellas [2020] EWHC 866 (Pat) – multi-patent pharmaceutical action concerning the treatment of anaemia with small molecule inhibitors

Don-Bur v Fluid Power – mechanical patent dispute in IPEC concerning trailer design

Trade marks 

Prime Online Ltd v Amazon Technologies, Inc (ongoing) ­– dispute concerning the trade name PRIME GAMING, with parallel proceedings in the IPO involving the bad faith ground

William Grant v Lidl [2021] CSOH 55 – assisted in Scottish litigation concerning the Hendrick’s gin brand

Medical devices company v Medical devices company – trade mark and passing off dispute relating to COVID-19 medical diagnostic tests

Medical devices company v Medical devices company – comparative advertising trade mark dispute concerning sutures

Various ongoing oppositions before the UKIPO

Other intellectual property rights

Songtradr v Ditto, Bluebox, Block8 – dispute concerning copyright and confidential information in blockchain software relating to music licensing, including issues of relative confidentiality and springboard injunctive relief

Selected cases observed or contributed to as a pupil:


Conversant v Huawei, ZTE – telecommunications patents action in a series of technical trials

Anan Kasei, Rhodia v Molycorp – assisted in drafting points of claim for a damages enquiry

Lufthansa v Astronics – assisted in preparing the trial skeleton in this patent action concerning plug sockets and electronic safety features

Philips v Asustek – joined telecoms appeals before the Court of Appeal

Mitsubishi v Archos, Xiaomi – jurisdictional aspects of a FRAND dispute


Trade marks and soft IP

Sky v SkyKick – assisted in preparation for the form of order hearing involving a qualified injunction

Glaxo v Sandoz – assisted in preparation for hearing before UKIPO regarding issue estoppels arising from related High Court proceedings concerning the colour purple on inhalers

Glaxo v Glenmark – trade mark and passing off dispute concerning the 3D shape mark for Glaxo’s inhalers

Duracell v Baruch – trade mark dispute concerning parallel imports and re-packaged goods

Apple v Lee – trade mark and design matter relating to counterfeit goods

Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi – appeal from EUIPO before the CJEU relating to collective marks


  • 2019-2020: 12-month pupillage at Three New Square to Miles Copeland, Jeremy Heald, Joe Delaney, Stuart Baran and Geoff Pritchard
  • 2017-2018: BPTC at BPP Birmingham: Outstanding; 1st in cohort
  • 2016-2017: GDL at BPP Birmingham: Distinction
  • 2012-2016: MChem Chemistry at Lincoln College, Oxford: 1st
    class. Part-II thesis in soft chemistry of solid- state crystalline compounds from the cerium oxychalcogenide series


Lord Denning and Lord Brougham scholarships, Hardwicke award, from Lincoln’s Inn

College Scholar, L H Martin prize, and Sidgwick Exhibitioner from Lincoln College, Oxford


In 2018-2019, Thomas worked at Carpmaels & Ransford LLP. He was involved with a pharmaceutical patents matter relating to anti-CGRP antibodies for the treatment of migraine.